Article: Cyclophosphamide-induced severe acute hyponatremic encephalopathy in patients with breast cancer: report of two cases

Background: Cyclophosphamide is an alkylating agent widely used in antineoplastic and immunosuppressive therapies. Symptomatic hyponatremia can be a rare but life-threatening complication in patients treated with cyclophosphamide.

Case Presentations: We report 2 patients who presented with severe acute hyponatremic encephalopathy after receiving their first cycles of a low-dose cyclophosphamide-containing regimen for breast cancer. In case 1, a 58-year-old female received the combination of docetaxel and cyclophosphamide, and in case 2, a 56-year-old female received the combination of doxorubicin and cyclophosphamide. Both patients recovered after correction of their serum sodium concentration without neurological deficits. Future cycles of chemotherapy were well tolerated without recurrence of hyponatremia after cyclophosphamide was discontinued from the respective regimens.

Conclusion: Clinicians must always keep in mind that acute hyponatremic encephalopathy can be induced by low-dose cyclophosphamide.

Citing Articles

Effects of Adriamycin-Cytoxan chemotherapy on hematological and electrolyte parameters among breast cancer patients.

Tadesse F, Leminie A Front Oncol. 2023; 13:1103013.

PMID: 37205205 PMC: 10185890. DOI: 10.3389/fonc.2023.1103013.

Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report.

Zhang L, Shi Y, Zhang J, Wu J, Jiang W Front Immunol. 2023; 14:1122629.

PMID: 36999036 PMC: 10049787. DOI: 10.3389/fimmu.2023.1122629.

Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosus: A case report.

Chen J, Jin Y, Li C, Li Z Medicine (Baltimore). 2020; 99(48):e22498.

PMID: 33235058 PMC: 7710175. DOI: 10.1097/MD.0000000000022498.

Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.

El-Shabrawy M, Mishriki A, Attia H, Aboulhoda B, Emam M, Wanas H Pharmacol Res Perspect. 2020; 8(5):e00659.

PMID: 32996719 PMC: 7525803. DOI: 10.1002/prp2.659.

Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.

Clifton K, Barnett C, Martinez A, Karuturi M, Saleem S, Litton J Breast J. 2018; 24(4):691-692.

PMID: 29498456 PMC: 6375476. DOI: 10.1111/tbj.13026.

References

1.

Harlow P, DeClerck Y, SHORE N, Ortega J, Carranza A, Heuser E . A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer. 1979; 44(3):896-8. DOI: 10.1002/1097-0142(197909)44:3<896::aid-cncr2820440316>3.0.co;2-9. View

2.

Hwang S, Lee H, Kim H, Lee E, Bae J . Life-threatening acute hyponatremia with generalized seizure induced by low-dose cyclophosphamide in a patient with breast cancer. J Breast Cancer. 2012; 14(4):345-8. PMC: 3268935. DOI: 10.4048/jbc.2011.14.4.345. View

3.

Berghmans T . Hyponatremia related to medical anticancer treatment. Support Care Cancer. 1996; 4(5):341-50. DOI: 10.1007/BF01788840. View

4.

Webberley M, Murray J . Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J. 1989; 65(770):950-2. PMC: 2429550. DOI: 10.1136/pgmj.65.770.950. View

5.

Biswas M, Davies J . Hyponatraemia in clinical practice. Postgrad Med J. 2007; 83(980):373-8. PMC: 2600061. DOI: 10.1136/pgmj.2006.056515. View

6.

Koo T, Bae S, Park J, Lee C, Park M, Kang C . Water intoxication following low-dose intravenous cyclophosphamide. Electrolyte Blood Press. 2014; 5(1):50-4. PMC: 3894507. DOI: 10.5049/EBP.2007.5.1.50. View

7.

Moses A, Miller M . Drug-induced dilutional hyponatremia. N Engl J Med. 1974; 291(23):1234-9. DOI: 10.1056/NEJM197412052912307. View

8.

Bruining D, van Roon E, de Graaf H, Hoogendoorn M . Cyclophosphamide-induced symptomatic hyponatraemia. Neth J Med. 2011; 69(4):192-5. View

9.

Salido M, Macarron P, Hernandez-Garcia C, DCruz D, Khamashta M, Hughes G . Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus. Lupus. 2003; 12(8):636-9. DOI: 10.1191/0961203303lu421cr. View

10.

Lee Y, Park J, Lee C, Bae S, Kim I, Kang C . Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. Nephrol Dial Transplant. 2009; 25(5):1520-4. DOI: 10.1093/ndt/gfp657. View

11.

Castillo J, Vincent M, Justice E . Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012; 17(6):756-65. PMC: 3380874. DOI: 10.1634/theoncologist.2011-0400. View

12.

Belton K, Thomas S . Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Postgrad Med J. 2000; 75(886):509-10. PMC: 1741308. DOI: 10.1136/pgmj.75.886.509. View

Cyclophosphamide-induced Severe Acute Hyponatremic Encephalopathy in Patients with Breast Cancer: Report of Two Cases